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The ubiquitin (Ub) system recognizes degradation signals of the
target proteins through the E3 components of E3-E2 Ub ligases. A
targeted substrate bears a covalently linked multi-Ub chain and is
degraded by the ATP-dependent 26S proteasome, which consists
of the 20S core protease and two 19S particles. The latter mediate
the binding and unfolding of a substrate protein before its transfer
to the interior of the 20S core. It is unclear how a targeted substrate
is delivered to the 26S proteasome, inasmuch as Rpn10p, the only
known proteasomal subunit that binds multi-Ub chains, has been
found to be not essential for degradation of many proteins in the
yeast Saccharomyces cerevisiae. Here we show that Ubr1p and
Ufd4p, the E3 components of two distinct Ub ligases, directly
interact with the 26S proteasome. Specifically, Ubr1p is shown to
bind to the Rpn2p, Rpt1p, and Rpt6p proteins of the 19S particle,
and Ufd4p is shown to bind to Rpt6p. These and related results
suggest that a substrate-bound Ub ligase participates in the de-
livery of substrates to the proteasome, because of affinity between
the ligase’s E3 component and specific proteins of the 19S particle.
E3 u N-end rule u ubiquitin fusion degradation pathway u Ubr1p u Ufd4p
Regulated proteolysis by the ubiquitin (Ub) system playsessential roles in the cell cycle, differentiation, stress re-
sponses, and many other processes (1–5). Ub is a 76-residue
protein whose covalent conjugation to other proteins, usually in
the form of a multi-Ub chain, marks these proteins for processive
degradation by the 26S proteasome, an ATP-dependent multi-
subunit protease (3, 6–8). The conjugation of Ub to other
proteins involves the formation of a thioester between the C
terminus of Ub and a specific cysteine of the Ub-activating (E1)
enzyme. The Ub moiety of E1;Ub thioester thereafter is
transesterified to a specific cysteine in one of several Ub-
conjugating (E2) enzymes. The Ub moiety of E2;Ub thioester
is conjugated, via the isopeptide bond, to the «-amino group of
either a substrate’s Lys residue or a Lys residue of another Ub
moiety, the latter reaction resulting in a substrate-linked
multi-Ub chain (9–11).
Most E2 enzymes function in complexes with proteins called E3.
The functions of E3s include the initial recognition of degradation
signals (degrons) in the substrate proteins, with different E3s
recognizing different classes of degrons. The E2-E3 complexes,
referred to as Ub ligases, mediate the formation of substrate-linked
multi-Ub chains (10, 12, 13). The ATP-dependent 26S proteasome,
which processively degrades a targeted, ubiquitylated† substrate,
consists of the 20S core protease and two 19S particles (6, 14). A
19S particle mediates the binding and unfolding of a substrate
protein before its transfer to the interior of the 20S core (6, 15–19).
It is unclear how a targeted substrate is delivered to the 26S
proteasome, inasmuch as Rpn10p (Mcb1pySun1p), the only known
proteasomal subunit that binds multi-Ub chains (20), is not essential
for degradation of many proteins in the yeast Saccharomyces
cerevisiae (21).
Here we show that Ubr1p and Ufd4p, the E3 components of
two distinct Ub-dependent proteolytic pathways (13, 22, 23),
directly interact with the 26S proteasome. Specifically, Ubr1p is
shown to bind to the Rpn2p (Sen3p), Rpt1p (Cim5p), and Rpt6p
(Cim3pySug1p) proteins of the 19S particle, and Ufd4p is shown
to bind to Rpt6p. These results suggest a mechanism for the
delivery of protein substrates to the proteasome.
Materials and Methods
Protein Expression in S. cerevisiae and Escherichia coli. Plasmid
construction protocols are available on request. S. cerevisiae RPN1
was isolated as a multicopy suppressor of the toxicity of co-
overproduced Ubr1p and Rad6p (Ubc2p), which were expressed
from the bidirectional PGAL1,10 promoter as described (24). RPN2,
RPN10, and RPN12 with their own promoter regions, and the ORFs
of RPN3, RPN11, RPT1, RPT2, RPT6, and PRE6 were amplified by
PCR from the DNA of S. cerevisiae YPH500. All PCR products
were verified by DNA sequencing. For the toxicity suppression
assays (Fig. 1), RPN1, RPN2, RPN10, and RPN12 were subcloned
into the high-copy vector pRS425 (25). The RPT1 and RPT6 ORFs
were subcloned into the low-copy vector pRS314CUP1 derived
from pRS314 (25), yielding p314CUP1RPT1 and p314CUP1RPT6,
in which RPT1 and RPT6 were expressed from the PCUP1 promoter.
For coimmunoprecipitation assays, the N-termini of Rpt6p, Pre6p,
and Ufd4p were extended with the hemagglutinin (HA) epitope
(23); alternatively, the FLAG epitope was added to the C termini
of Rpt6p and Rpn1p (26). For glutathione S-transferase (GST)-
pulldown assays, the ORFs of RPN1, RPN2, RPN3, RPN10, RPN11,
RPN12, RPT1, RPT2, RPT6, and PRE6 were fused in-frame to the
39 end of GST-coding sequence in pGEX-4T-3 (Amersham Phar-
macia). The C-terminally FLAG-tagged alleles of RPN1 and
RPN10 were subcloned into pET-11c (Novagen). E. coli BL21
(DE3) (26) was used to express the GST fusions, as well as
Rpn1p-FLAG and Rpn10p-FLAG.
Pulse–Chase and GST-Pulldown Assays. The Ub protein reference
(UPR)-based plasmids expressing dihydrofolate reductase
(DHFR)-HA-UbR48-X-bgal (b-galactosidase) (see Results for
notations) were described (27). The pulse–chase procedures
(Fig. 2) were described as well (22, 28). In GST-pulldown assays,
’1 mg of a GST fusion protein or GST alone was diluted to 0.5
ml in the loading buffer (1% Triton X-100y10% glyceroly0.5 M
NaCly1 mM EDTAy50 mM TriszHCl, pH 8.0), and incubated
with 10 ml (bed volume) of the glutathione-agarose beads
(Sigma) for 1 h at 4°C. The beads were washed three times with
Abbreviations: Ub, ubiquitin; HA, hemagglutinin; GST, glutathione S-transferase; UPR, Ub
protein reference; DHFR, dihydrofolate reductase; bgal, b-galactosidase; UFD, Ub fusion
degradation.
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1 ml of the binding buffer (0.05% Triton X-100y10% glycer-
oly50 mM NaCly50 mM Na-Hepes, pH 7.5). The washed beads
were incubated with cell extracts containing FLAG-Ubr1p (Fig.
3A), or with purified FLAG-Ubr1p (Fig. 3B), or with cell extracts
containing either Rpn1p-FLAG or Rpn10p-FLAG (Fig. 4 A and
B), or HA-Ufd4p (Fig. 5A) at 4°C for 2 h. The incubation buffer
for the assay with purified FLAG-Ubr1p contained ovalbumin
(Sigma) at 1 mgyml in the binding buffer. The beads were
washed three times with the binding buffer, followed by
SDSyPAGE of the retained proteins and immunoblotting with
either anti-FLAG antibody (Sigma) or anti-HA antibody
(Babco, Berkeley, CA).
CoimmunoprecipitationyImmunoblotting. FLAG-Ubr1p, bearing
the N-terminal FLAG epitope, was expressed from the PADH1
promoter in the low-copy vector pRS315 (25). The N-terminally
HA-tagged HA-Rpt6p, HA-Pre6p, and HA-Ufd4p and the
C-terminally FLAG-tagged Rpt6p-FLAG were expressed from
the induced PCUP1 promoter in the low-copy vector pRS314 (25).
The C-terminally FLAG-tagged Rpn1p-FLAG was expressed
from its own promoter in pRS425. S. cerevisiae was grown in
synthetic-dextrose medium (26, 28) containing 0.2 mM CuSO4 to
OD600 ’1.0. Cells were disrupted by vortexing with glass beads
in 0.05% Triton X-100, 50 mM NaCl, 50 mM Na-Hepes (pH 7.5)
containing several protease inhibitors (27).
Results
Ubr1p, the E3 of the N-End Rule Pathway, Binds to the Proteasome.
Ubr1p (also called N-recognin), the 225K E3 of the S. cerevisiae
N-end rule pathway, targets proteins that bear certain (desta-
bilizing) N-terminal residues. Two substrate-binding sites of
Ubr1p recognize two classes of destabilizing N-terminal resi-
dues: basic and bulky hydrophobic (13). Yet another substrate-
binding site of Ubr1p targets proteins that bear internal (non-
N-terminal) degrons (29). Similar, but distinct, versions of the
N-end rule pathway are present in all organisms examined, from
prokaryotes to fungi and mammals (13). Previous work has
shown that overexpression of the pathway’s Ub ligase, through
co-overexpression of its E2 (Rad6p, also called Ubc2p) and E3
(Ubr1p) components, is toxic to S. cerevisiae (24).
In the present work, we found that RPN1 (NAS1yHRD2) (30,
31), which encodes a ’110 K protein of the proteasome’s 19S
particle, was a multicopy suppressor of the toxicity of co-
overexpressed Ubr1p and Rad6p (Fig. 1 A and B, and data not
shown). Because Rpn1p is essential for cell viability (30), it could
be that the toxicity of co-overexpressed Ubr1p and Rad6p
Fig. 1. Toxicity of overexpressed N-end rule pathway is decreased by overexpressed Rpn1p and enhanced by overexpressed Rpt1p or Rpt6p. The S. cerevisiae
strain JD52 (23) was transformed with pKM1313, a low-copy, URA3-based plasmid expressing UBR1 and RAD6 from the bidirectional PGAL1,10 promoter (24). The
pKM1313-containing JD52 cells were transformed either with the pRS425 vector (A), RPN1 (expressed from its own promoter in pRS425) (B), RPT1 (expressed from
the PCUP1 promoter in p314CUP1RPT1) (C), or RPT6 (expressed from the PCUP1 promoter in p314CUP1RPT6) (D). (E and F) JD52 cells carrying both pKM1313 and
the RPN1-expressing plasmid were further transformed with p314CUP1RPT1 (E) and p314CUP1RPT6 (F), respectively. Shown here are plates with cells grown in
the galactose-containing minimal medium containing 0.2 mM CuSO4 for 4 days at 30°C. On dextrose-containing plates (no overexpression of Ubr1p and Rad6p),
all transformants grew at similar rates, irrespective of the presence of overexpressed Rpn1p, Rpt1p, or Rpt6p (data not shown).
Fig. 2. Overexpression of Rpn1p inhibits degradation of N-end rule sub-
strates. A UPR-based pulse–chase assay was used (see Results). S. cerevisiae
JD52 (UBR1) cells coexpressing either DHFR-HA-UbR48-Leu-bgal (A) or DHFR-
HA-UbR48-His-bgal (B), and either Rpn1p (expressed from its own promoter in
pRS425) or pRS425 alone were labeled with [35S]methionine for 5 min at 30°C,
followed by a chase for 0, 10, and 30 min. Cell extracts were immunoprecipi-
tated with both anti-bgal and anti-HA antibodies, followed by SDSy12%
PAGE, autoradiography, and quantitation using PhosphorImager (Molecular
Dynamics). (C) His-bgal and Leu-bgal decay curves calculated from the UPR-
based data in A and B as described (28, 32). The bands of X-bgals and the
reference protein DHFR-HA-UbR48 (‘‘ref’’) are indicated.
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resulted in part from overdegradation of Rpn1p, which would
have accounted for the observed alleviation of toxicity through
overexpression of Rpn1p. However, pulse–chase assays with
Rpn1p have shown it to be a long-lived protein in either
wild-type cells or cells co-overexpressing Ubr1p and Rad6p
(data not shown). It also was found that overexpression of Rpn1p
had no effect on the expression levels of co-overexpressed Ubr1p
and Rad6p (data not shown).
We then tested, using pulse–chase assays, whether overex-
pression of Rpn1p perturbed the degradation of normally short-
lived substrates of the N-end rule pathway. In these assays, the
E. coli bgal-based test proteins were expressed as components of
fusions of the form DHFR-HA-UbR48-X-bgal, where X was
either His, a type 1 (basic) destabilizing residue, or Leu, a type
2 (hydrophobic) destabilizing residue (13); DHFR-HA was the
C-terminally HA-tagged mouse DHFR; UbR48 was the Ub
moiety containing Arg instead of Lys at position 48 (27, 28, 32);
and bgal was E. coli bgal. Deubiquitylating enzymes (33) co-
translationally cleave these fusions at the Ub-bgal junction,
yielding the long-lived DHFR-HA-UbR48 reference protein and
a test protein, either His-bgal or Leu-bgal. A reference protein
improves the assay’s accuracy by serving as a built-in control for
variations in the expression levels, immunoprecipitation effi-
ciency, and other sources of data scatter in a pulse–chase assay.
The above method for producing a reference protein is called the
UPR technique (28, 32). As shown in Fig. 2, the in vivo
degradation of both His-bgal and Leu-bgal substrates of the
N-end rule pathway was significantly impaired in the presence of
overexpressed Rpn1p.
To determine whether other proteins of the 19S particle were
similar to Rpn1p in its ability to suppress the toxicity of
overexpressed N-end rule pathway, we overexpressed Rpn2p,
Rpn10p, and Rpn12p, by transforming cells that co-overex-
pressed Ubr1p and Rad6p (from the PGAL1,10 promoter) with a
high-copy vector expressing, separately, Rpn2p, Rpn10p, and
Rpn12p from their own promoters. We also tested Rpt1p and
Rpt6p, two of the six ATPases of the 19S particle (16), by
overexpressing them from the copper-induced PCUP1 promoter
in a low-copy vector. In contrast to the results with Rpn1p (Fig.
1 A and B), none of these proteins could alleviate, upon
Fig. 3. Ubr1p, the E3 of the N-end rule pathway, is physically associated with the 26S proteasome. (A and B) Ubr1p interacts with Rpn2p, Rpt1p, and Rpt6p
in GST-pulldown assays. Extracts of S. cerevisiae containing overexpressed FLAG-Ubr1p (A) or the purified FLAG-Ubr1p protein (B) were incubated with
glutathione-agarose beads preloaded with the indicated GST fusions. The retained proteins were eluted, fractionated by SDSy8% PAGE, and immunoblotted
with anti-FLAG antibody. Approximately equal amounts of different GST fusions were immobilized on glutathione-agarose beads in these assays, as verified by
Coomassie staining (data not shown). (C and D) In vivo association of Ubr1p and Rpt6p. Extracts of S. cerevisiae AVY107 (ubr1D) expressing either both
FLAG-Ubr1p and HA-Rpt6p, or FLAG-Ubr1p alone, or HA-Rpt6p alone were incubated with anti-FLAG antibody (C) or anti-HA antibody (D). The immunopre-
cipitated proteins were separated by SDSy12% PAGE and transferred to nitrocellulose membrane. The top halves of C and D show the results of immunoblotting
with anti-FLAG antibody; the bottom halves show the analogous data with anti-HA antibody. (E) Coimmunoprecipitation of Pre6p and Ubr1p. Extracts of
S. cerevisiae AVY107 (ubr1D) expressing both FLAG-Ubr1p and HA-Pre6p, FLAG-Ubr1p alone, or HA-Pre6p alone were incubated with anti-HA antibody, followed
by the immunoprecipitationyimmunoblotting described in C and D.
Fig. 4. Rpn1p interacts with Rpt1p, Rpt6p, and Rpn10p. E. coli-expressed
Rpn1p-FLAG (A) and Rpn10p-FLAG (B), both carrying the FLAG epitope at the C
terminus, were incubated with glutathione-agarose beads preloaded with the
indicated GST fusions. The retained proteins were fractionated by SDSyPAGE,
followed by immunoblotting with anti-FLAG antibody. Approximately equal
amounts of different GST fusions were immobilized on glutathione-agarose
beads in these assays, as verified by Coomassie staining (data not shown).








overexpression, the growth defect caused by co-overexpressed
Ubr1p and Rad6p (data not shown). Moreover, we found that
overexpression of either Rpt1p or Rpt6p had an effect opposite
to that of overexpressed Rpn1p: the toxicity of co-overexpressed
Ubr1p and Rad6p was higher in the presence of overexpressed
Rpt1p or Rpt6p (Fig. 1 C and D; compare with Fig. 1 A and B).
In a control experiment, the overexpression of Rpt1p or Rpt6p
in cells that did not co-overexpress Ubr1p and Rad6p was not at
all toxic (data not shown). These results suggested that Rpt1p
and Rpt6p may interact with a component(s) of the N-end rule
pathway, perhaps with Ubr1p, the pathway’s E3. To verify this
conjecture, we carried out GST-pulldown assays.
In these experiments, Ubr1p was N-terminally tagged with the
FLAG epitope. The N-terminal FLAG tag did not impair the
function of Ubr1p (A. Webster and A.V., unpublished data).
Rpt1p and Rpt6p were expressed in E. coli as fusions to the C
terminus of GST. Extracts of S. cerevisiae overexpressing FLAG-
Ubr1p were incubated with glutathione-agarose beads pre-
loaded with GST-Rpt1p, GST-Rpt6p, or GST alone. The bound
proteins were eluted, fractionated by SDSyPAGE, and immu-
noblotted with a monoclonal anti-FLAG antibody. Remarkably,
GST-Rpt6p was found to bind FLAG-Ubr1p; a smaller, but
significant, amount of FLAG-Ubr1p also was bound by GST-
Rpt1p, whereas no FLAG-Ubr1p was bound by GST alone (Fig.
3A, lanes 2, 7, and 8).
Could Ubr1p interact with other proteins of the 26S protea-
some as well? Using the same assay, we discovered that GST-
Rpn2p was also able to bind FLAG-Ubr1p, whereas all of the
other tested proteasomal components (GST-Rpn1p, GST-
Rpn3p, GST-Rpn10p, GST-Rpn11p, GST-Rpn12p, GST-Rpt2p,
and GST-Pre6p, the latter a component of the 20S core protea-
some) did not bind to FLAG-Ubr1p (Fig. 3A). Coomassie
staining of the eluted, SDSyPAGE-fractionated proteins con-
firmed that the amounts of different GST fusions prebound to
glutathione-agarose beads in the pulldown assays were approx-
imately equal (data not shown).
To determine whether Ubr1p binds to Rpt1p, Rpt6p, and Rpn2p
directly, we carried out pulldown assays with purified FLAG-Ubr1p
(a gift from F. Du and A. Webster, California Institute of Tech-
nology) (Fig. 3B). FLAG-Ubr1p was overexpressed in S. cerevisiae
and purified in three consecutive steps: anti-FLAG antibody affin-
ity chromatography; Rad6p (E2) affinity chromatography; and gel
filtration (F. Du, A. Webster, and A.V., unpublished data). In
agreement with the results obtained by using extracts from cells
overexpressing FLAG-Ubr1p (Fig. 3A), the purified FLAG-Ubr1p
bound to the purified GST-Rpt1p, GST-Rpt6p, and GST-Rpn2p,
but not to GST-Rpn1p, GST-Rpn10p, or GST alone (Fig. 3B).
FLAG-Ubr1p used in this assay was purified from S. cerevisiae
overexpressing this protein. Although FLAG-Ubr1p was at least
95% pure by Coomassie staining, one would like to purify S.
cerevisiae Ubr1p from a noneukaryotic host as well, to preclude the
unlikely possibility that a trace amount of a Ubr1p-interacting
protein in the preparation of purified Ubr1p could mediate the
binding of Ubr1p to Rpt1p, Rpt6p, and Rpn2p. Attempts to
overexpress the 225K Ubr1p in E. coli have not been successful thus
far.
Further tests used a coimmunoprecipitationyimmunoblotting
assay to examine the in vivo interaction between Ubr1p and
Rpt6p. FLAG-Ubr1p was co-overexpressed in ubr1 S. cerevi-
siae with HA-Rpt6p, which bore the N-terminal HA-derived
epitope. The controls included congenic cells expressing either
FLAG-Ubr1p alone or HA-Rpt6p alone. Proteins were immu-
noprecipitated from cell extracts with anti-FLAG antibody,
followed by SDSyPAGE and immunoblotting with either an-
ti-HA antibody (Fig. 3C Lower) or anti-FLAG antibody (Fig. 3C
Upper). The results indicated that HA-Rpt6p was specifically
coprecipitated with FLAG-Ubr1p by anti-FLAG antibody. We
also carried out the reciprocal coimmunoprecipitation assay and
found that FLAG-Ubr1p was specifically coprecipitated with
HA-Rpt6p by anti-HA antibody (Fig. 3D).
In the in vitro pulldown assays, FLAG-Ubr1p did not interact
with GST-Pre6p, a GST fusion to a protein of the 20S core
protease (Fig. 3A, lane 9). To determine whether Ubr1p is
associated with the mature 26S proteasome in vivo, FLAG-
Ubr1p and HA-Pre6p (N-terminally tagged with the HA
epitope) were co-overexpressed in ubr1D cells. Proteins were
precipitated from cell extracts with anti-HA antibody and sep-
arated by SDSyPAGE, followed by immunoblotting with either
anti-FLAG or anti-HA antibody. FLAG-Ubr1p was found to be
specifically coprecipitated with HA-Pre6p by anti-HA antibody
(Fig. 3E). Thus, GST-pulldown assays with either crude or
purified FLAG-Ubr1p (Fig. 3 A and B) and the coimmunopre-
cipitation assays (Fig. 3 C–E) demonstrated that Ubr1p, the E3
of the N-end rule pathway, is physically associated with the 26S
proteasome. Moreover, Ubr1p was found to interact with more
than one protein of the 19S particle (Fig. 3 A and B).
As described above, overexpression of Rpn1p, a non-ATPase
component of the 19S particle, inhibited the activity of the N-end
rule pathway (Fig. 2). What might be the mechanism of this
inhibition? Overexpression of Rpn1p apparently did not have a
significant effect on the function of the 26S proteasome, inas-
much as cells overexpressing Rpn1p were not hypersensitive to
either an arginine analog canavanine or high temperature (data
Fig. 5. Ufd4p, the E3 of the UFD pathway, is physically associated with the
proteasome. (A) Ufd4p interacts with Rpt6p in the GST-pulldown assay. Ex-
tracts of S. cerevisiae containing overexpressed HA-Ufd4p were incubated
with glutathione-agarose beads preloaded with different GST fusions, as
indicated. The retained proteins were eluted, fractionated by SDSy8% PAGE,
and immunoblotted with anti-HA antibody. Approximately equal amounts of
different GST fusions were immobilized on glutathione-agarose beads in
these assays, as verified by Coomassie staining (data not shown). (B) In vivo
association of Ufd4p and Rpt6p. Extracts of S. cerevisiae JD52 (UBR1) express-
ing both HA-Ufd4p and Rpt6p-FLAG, HA-Ufd4p alone, or Rpt6p-FLAG alone
were incubated with anti-HA antibody. The immunoprecipitated proteins
were separated by SDSy10% PAGE and transferred to nitrocellulose mem-
brane. (Upper) The results of immunoblotting with anti-HA antibody. (Lower)
The data with anti-FLAG antibody. (C) Coimmunoprecipitation of Rpn1p and
Ufd4p. Extracts of S. cerevisiae JD52 expressing both HA-Ufd4p and Rpn1p-
FLAG, HA-Ufd4p alone, or Rpn1p-FLAG alone were incubated with anti-HA
antibody, followed by the immunoprecipitationyimmunoblotting procedure
described in B, except that SDSy7% PAGE was used.
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not shown). Hypersensitivity to these stressors is characteristic of
yeast strains that have impaired proteasome components (6, 14).
Overexpression of Rpn1p in wild-type cells (in the absence of
co-overexpression of Ubr1p and Rad6p) did not result in a
growth defect (data not shown). Furthermore, GST-pulldown
assays indicated that GST-Rpn1p did not directly interact with
Ubr1p (Fig. 3), ruling out the possibility that overproduced
Rpn1p may decrease the toxicity of overexpressed N-end rule
pathway by sequestering the overproduced Ubr1p. It was also
unlikely that the overproduced, free Rpn1p competed with the
26S proteasome by interacting with substrate-linked multi-Ub
chains, because Rpn1p was unable to bind isolated multi-Ub
chains (data not shown).
As described above, overexpression of either Rpt1p or Rpt6p,
the ATPase subunits of the 19S particle, was found to increase
the toxicity of co-overexpressed Ubr1p and Rad6p (Fig. 1 C and
D; compare with Fig. 1 A). Therefore, we examined the possi-
bility that the overexpressed Rpn1p may alleviate the toxicity of
co-overexpressed Ubr1p and Rad6p by sequestering Rpt1p and
Rpt6p, both of which were shown to interact with Ubr1p (Fig. 3).
We began by determining, using the GST-pulldown assay,
whether Rpn1p could directly bind to Rpt1p andyor Rpt6p.
S. cerevisiae Rpn1p-FLAG (bearing the C-terminal FLAG
epitope) was expressed in E. coli and incubated with glutathione
agarose beads containing prebound GST-Rpt1p, GST-Rpt6p, or
GST alone. The bound proteins were eluted, separated by
SDSyPAGE, and immunoblotted with anti-FLAG antibody.
Rpn1p was found to interact directly with both GST-Rpt1p and
GST-Rpt6p, but not with GST alone (Fig. 4A, lanes 1, 5, and 6).
We also found that Rpn1p-FLAG directly interacted with
GST-Rpn10p, the protein of the 19S particle that binds to
multi-Ub chains (Fig. 4A). Rpn1p-FLAG did not interact, in this
assay, with other tested proteins of the 19S particle (Rpn2p and
Rpn12p) and also did not interact with the Pre6p protein of the
20S core (Fig. 4A). A direct Rpn1p-Rpn10p interaction also was
observed in a reciprocal GST-pulldown assay, in which the
E. coli-expressed Rpn10p-FLAG was shown to be retained by the
prebound GST-Rpn1p, but not by GST-Rpn2p (Fig. 4B). Rpn1p,
Rpn2p, Rpn10p, and the six Rpt ATPases Rpt1p-Rpt6p form the
base of the 19S particle that is proximal to the 20S core of the
26S proteasome (16, 31).
Further tests indicated that overexpression of either Rpt1p or
Rpt6p antagonized the ability of overexpressed Rpn1p to sup-
press the toxicity of overexpressed N-end rule pathway (Fig. 1 E
and F; compare with Fig. 1B). Taken together, these results
(Figs. 1, 3, and 4) strongly suggested that Rpn1p, which does not
bind to Ubr1p, suppresses the toxicity of co-overexpressed
Ubr1p and Rad6p at least in part through the demonstrated
binding of Rpn1p to both Rpt1p and Rpt6p, either of which binds
to Ubr1p. Schauber et al. (34) have shown that Rad23p, which
bears an N-terminal Ub-like moiety, is another high-copy sup-
pressor of the toxicity of overexpressed N-end rule pathway.
Rad23p was found to interact with Rpt1p, Rpt6p, and Rpn10p
(35, 36). In the present work, the same three proteins of the 19S
particle were shown to interact with Rpn1p, another protein of
this particle, suggesting that overexpression of Rpn1p and
Rad23p suppresses the toxicity of overexpressed N-end rule
pathway through similar mechanisms.
Ufd4p, the E3 of the Ub Fusion Degradation (UFD) Pathway, Binds to
the Proteasome. The substrates of another Ub-dependent proteo-
lytic system, termed the UFD pathway, include proteins bearing at
their N termini a ‘‘nonremovable’’ Ub moiety (23, 37, 38). A partial
or complete resistance of these Ub-containing proteins to deubiq-
uitylating enzyme-mediated cleavage stems from either alterations
of the last residue of Ub moiety or the presence of proline at the
C-terminal side of the Ub-protein junction (23). Ufd4p, a member
of the HECT family of E3 proteins (39), is the E3 of the S. cerevisiae
UFD pathway (23). Sequence comparisons did not detect statisti-
cally significant similarities between the 225K Ubr1p and the 167K
Ufd4p. We used the GST-pulldown and coimmunoprecipita-
tionyimmunoblotting assays to determine whether Ufd4p also
could bind to the proteasome.
Ufd4p was N-terminally tagged with the HA epitope, which
did not impair the function of Ufd4p (data not shown). In the
GST-pulldown assay, extracts from S. cerevisiae overexpressing
HA-Ufd4p were incubated with glutathione-agarose beads pre-
loaded with GST-Rpn1p, GST-Rpn2p, GST-Rpn3p, GST-
Rpn10p, GST-Rpn11p, GST-Rpn12p, GST-Rpt1p, GST-Rpt2p,
GST-Rpt6p, or GST alone. The retained proteins were fraction-
ated by SDSyPAGE and immunoblotted with anti-HA antibody.
As shown in Fig. 5A, HA-Ufd4p was found to be specifically
bound to GST-Rpt6p, one of three proteins of the 19S particle
that interacted with Ubr1p, the E3 of the N-end rule pathway.
None of the other tested proteasomal proteins were able to
interact with HA-Ufd4p in the GST-pulldown assay (Fig. 5A).
We then examined the in vivo association of Ufd4p with
Rpt6p. HA-Ufd4p was co-overexpressed in S. cerevisiae with
Rpt6p-FLAG, which bore the C-terminal FLAG epitope. The
controls included congenic cells expressing either HA-Ufd4p
alone or Rpt6p-FLAG alone. Proteins were immunoprecipitated
from cell extracts with anti-HA antibody, followed by
SDSyPAGE and immunoblotting with either anti-HA antibody
(Fig. 5B Upper) or anti-FLAG antibody (Fig. 5B Lower). The
results indicated that Rpt6p-FLAG was specifically coprecipi-
tated with HA-Ufd4p by anti-HA antibody.
If Ufd4p interacts with the mature proteasome, one would
expect Rpn1p, which did not directly interact with Ufd4p (Fig.
5A), to be coimmunoprecipitated with HA-Ufd4p. To test this
conjecture, HA-Ufd4p was co-overexpressed in S. cerevisiae with
Rpn1p-FLAG, which bore the C-terminal FLAG epitope. The
controls included congenic cells expressing either HA-Ufd4p
alone or Rpn1p-FLAG alone. Extracts were immunoprecipi-
tated with anti-HA antibody, followed by SDSyPAGE and
immunoblotting with either anti-HA antibody (Fig. 5C Upper) or
anti-FLAG antibody (Fig. 5C Lower). Rpn1p-FLAG was indeed
specifically coprecipitated with HA-Ufd4p by anti-HA antibody.
Taken together, the GST-pulldown and coimmunoprecipitation
results (Fig. 5) demonstrated that Ufd4p, the E3 of the UFD
pathway, was physically associated with the proteasome.
Discussion
It has been unclear how the Ub system delivers its substrates to
the 26S proteasome for processive degradation. Two structural
elements of a targeted, Ub-conjugated substrate could serve as
ligands for the substrate’s docking at the 26S proteasome: a
substrate-linked multi-Ub chain andyor a cognate E3-E2 com-
plex reversibly bound to the substrate’s degron. Thus far,
Rpn10p is the only proteasomal component known to bind
multi-Ub chains; it also binds to chain-bearing model substrates
(refs. 10, 20, and 21, and our unpublished data). However,
S. cerevisiae stains lacking Rpn10p were found to be impaired in
the degradation of only some of the model substrates and did not
exhibit aberrant phenotypes characteristic of proteolysis-
impaired proteasome mutants (10, 21).
Our discovery that Ubr1p and Ufd4p, the E3 components of,
respectively, the N-end rule pathway and the UFD pathway,
directly interact with specific proteins of the 26S proteasome
suggests a general mechanism for the delivery of targeted
substrates to the proteasome. In this model, the E3 component
of a Ub-dependent pathway binds (as an E3-E2 complex) to a
cognate degron of a target protein and initiates, either sequen-
tially or concurrently, two sets of processes: (i) the formation of
a substrate-linked multi-Ub chain, through the activity of sub-
strate-bound Ub ligase (E3-E2) complex, and (ii) the delivery of
an E3-bound substrate to the chaperone-like proteins of the 26S








proteasome, through interactions between the E3 and specific
proteins of the 19S particle. A key assumption of this model is
that the demonstrated physical affinity between an E3 and the
proteasome is essential for the activity (at least for the normal
level of activity) of an E3-mediated proteolytic pathway. In the
case of the N-end rule pathway, this prediction can be tested, for
example, through the mapping of a site(s) in the 225K Ubr1p that
mediates its binding to Rpn2p, Rpt1p, and Rpt6p of the 19S
particle. The site(s) thus identified then could be mutated
in ways that leave intact the other functions of Ubr1p, such as its
binding to substrates, to the Rad6p E2 enzyme, and the previ-
ously described, RING finger-dependent activity of Ubr1p in the
Rad6pyUbr1p-mediated formation of a substrate-linked
multi-Ub chain (27). A similar approach could be used to test the
model’s assumption in regard to the demonstrated Ufd4p-Rpt6p
interaction.
Specific functions of either the Ufd4p-Rpt6p interaction or the
interactions of Ubr1p with Rpn2p, Rpt1p, and Rpt6p of the 19S
particle are unknown, in part because it is largely unknown how the
proteins of this particle contribute to the proteasome-mediated
proteolysis. It has been shown that Rpt1p-Rpt6p, the six ATPases
of the 19S particle, are not functionally redundant, and that they
cooperate in preparing individual substrates for degradation by the
20S core of the proteasome (40). It is likely that the functional role
of the Ubr1p-Rpn2p interaction is different from those of the
Ubr1p-Rpt1p and Ubr1p-Rpt6p interactions, because overexpres-
sion of Rpn2p was found to have virtually no effect on the toxicity
of co-overexpressed Ubr1p and Rad6p, whereas overexpression of
Rpt1p and Rpt6p increased this toxicity (see above). One possibility
is that the non-ATPase Rpn2p protein of the 19S particle functions
as the main Ubr1p affinity anchor, whereas the Ubr1p-binding
ATPases Rpt1p and Rpt6p mediate the unfolding of a Ubr1p-
bound substrate before its translocation into the 20S core. If so, the
observed increase in the toxicity of overexpressed N-end rule
pathway in the presence of free (overproduced) Rpt1p or Rpt6p
may result from their binding to the Ubr1p moiety of the Ubr1p-
Rad6p complex and their facilitation of the unfolding of Ubr1p-
bound substrates before docking at the proteasome. Given the
differences between Ubr1p and Ufd4p E3s in regard to their ligands
in the 19S particle (unlike Ubr1p, the Ufd4p E3 did not bind to
either Rpt1p or Rpn2p), it should be of interest to determine
whether Rpt6p is, in fact, the only significant ligand of Ufd4p in the
proteasome.
Several aspects of the proposed delivery mechanism remain
unconstrained by the available evidence. For example, if the
demonstrated Ubr1p-proteasome and Ufd4p-proteasome interac-
tions (Figs. 3–5) prove relevant to the functional activity of the
N-end rule and UFD pathways, one would like to determine how
many of the distinct E3s in a cell interact with the proteasome and
what proteins of the proteasome these E3s bind to. Another
important question is whether the Ubr1p-dependent formation of
a substrate-linked multi-Ub chain is required, in vivo, for the
docking of a Ubr1p-bound substrate at the Ubr1-binding site of the
proteasome. An alternative model is that these two Ubr1p-
mediated, substrate-centered processes (the chain formation and
the docking at the proteasome) take place concurrently and
independently.
The previously proposed function of a substrate-linked
multi-Ub chain is to serve as a dissociation-slowing device (9).
Specifically, if the rate-limiting step that precedes the first
proteolytic cleavages of a proteasome-bound substrate is the
substrate’s unfolding by chaperones of the 19S particle, then a
decrease in the rate of dissociation of the proteasome-substrate
complex, brought about by the multi-Ub chain, should facilitate
substrate’s degradation: the longer the allowed ‘‘waiting’’ time,
the greater the probability of a required unfolding event (13).
Similar considerations may apply to the function of E3-mediated
binding of a substrate to the proteasome.
The main result of this work is that the E3 components of two
distinct Ub ligases are physically associated with specific proteins
of the 26S proteasome. We discussed the mechanistic and
functional implications of this advance.
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